Article Cited by others

ORIGINAL ARTICLE

Role of protein kinase C β and vascular endothelial growth factor receptor in malignant pleural mesothelioma: Therapeutic implications and the usefulness of Caenorhabditis elegans model organism

Loganathan Sivakumar, Kanteti Rajani, Siddiqui Shahid S, El-Hashani Essam, Tretiakova Maria, Vigneswaran Hari, Cervantes Gustavo, Natarajan Viswanathan, Husain Aliya N, Vokes Everett E, Kindler Hedy L, Salgia Ravi

Year : 2011| Volume: 10| Issue : 1 | Page no: 4-4

   This article has been cited by
 
1 Is galectin-3 antibody a useful marker in the diagnosis of malignant pleural mesothelioma?
Mlika, M. and Ayadi-Kaddour, A. and Ksantini, M. and Bouraoui, S. and Mzabi, S. and El Mezni, F.
Journal of Immunoassay and Immunochemistry. 2013; 34(2): 111-125
[Pubmed]  [Google Scholar]
2 IS GALECTIN-3 ANTIBODY A USEFUL MARKER IN THE DIAGNOSIS OF MALIGNANT PLEURAL MESOTHELIOMA?
Mona Mlika,Aida Ayadi-Kaddour,Meriem Ksantini,Saadia Bouraoui,Sabah Mzabi,Faouzi El Mezni
Journal of Immunoassay and Immunochemistry. 2013; 34(2): 111
[Pubmed]  [Google Scholar] [DOI]
3 The mechanisms that regulate the localization and overexpression of VEGF receptor-2 are promising therapeutic targets in cancer biology
Kampen, K.R.
Anti-Cancer Drugs. 2012; 23(4): 347-354
[Pubmed]  [Google Scholar]
4 Cediranib in patients with malignant mesothelioma: A phase II trial of the University of Chicago Phase II Consortium
Campbell, N.P. and Kunnavakkam, R. and Leighl, N. and Vincent, M.D. and Gandara, D.R. and Koczywas, M. and Gitlitz, B.J. and Agamah, E. and Thomas, S.P. and Stadler, W.M. and Vokes, E.E. and Kindler, H.L.
Lung Cancer. 2012; 78(1): 76-80
[Pubmed]  [Google Scholar]
5 Sphingosine Kinase 1 Is Required for Mesothelioma Cell Proliferation: Role of Histone Acetylation
Kalari, S. and Moolky, N. and Pendyala, S. and Berdyshev, E.V. and Rolle, C. and Kanteti, R. and Kanteti, A. and Ma, W. and He, D. and Husain, A.N. and Kindler, H.L. and Kanteti, P. and Salgia, R. and Natarajan, V.
PLoS ONE. 2012; 7(9)
[Pubmed]  [Google Scholar]
6 Cediranib in patients with malignant mesothelioma: A phase II trial of the University of Chicago Phase II Consortium
Nicholas P. Campbell,Rangesh Kunnavakkam,Natasha Leighl,Mark D. Vincent,David R. Gandara,Marianna Koczywas,Barbara J. Gitlitz,Edem Agamah,Sachdev P. Thomas,Walter M. Stadler,Everett E. Vokes,Hedy L. Kindler
Lung Cancer. 2012; 78(1): 76
[Pubmed]  [Google Scholar] [DOI]
7 The mechanisms that regulate the localization and overexpression of VEGF receptor-2 are promising therapeutic targets in cancer biology
Kim R. Kampen
Anti-Cancer Drugs. 2012; 23(4): 347
[Pubmed]  [Google Scholar] [DOI]

 

Read this article